| Value | ₹22.02 Cr |
|---|---|
| Execution period | 18 months |
BSE filing, NSE: EXPOGAS. Summary written from the filing by ALFA Finder's alert engine.
Expo Engineering and Projects Ltd: key numbers
- Share price
- ₹82.55
- Market cap
- ₹188.2 Cr
- Revenue (annual)
- ₹68.23 Cr
- Net profit (annual)
- ₹1.74 Cr
- P/E (TTM)
- 144.3×Sector 51.5×
- Promoter holding
- 55.72%-1.23% QoQ
- FII holding
- 12.80%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Expo Engineering and Projects Ltd
All →Expo Engineering and Projects Investor Presentation: Key Takeaways
Q2 FY27 revenue flat YoY at ₹15.01 Cr; EBITDA ₹1.66 Cr (11.05% margin); PAT ₹0.74 Cr, down 13% YoY. Net order book ₹141.41 Cr.
Expo Engineering and Projects Q2 FY27 Results: Net Profit ₹0.7 Cr, Down 12.5% YoY
Expo Engineering and Projects Ltd reported revenue from operations of ₹15 Cr (+0.0% YoY) and net profit of ₹0.7 Cr (-12.5% YoY) for Q2 FY27.
- Key figure
- Net profit ₹0.7 Cr · -12.5% YoY
Expo Engineering and Projects Board Meeting Date
Expo Engineering scheduled a board meeting on 30 October 2026 to approve unaudited Q2 FY27 results. It is an advance meeting notice with no financial transaction.
Expo Engineering and Projects Convertible Warrants
Expo Engineering's 31,45,715 warrant-conversion shares, issued at Rs.70 each, received BSE trading approval. Listing is effective October 23, 2026, raising about Rs.22 Crore.
- Value
- ₹22.02 Cr
Expo Engineering and Projects Convertible Warrants
Expo Engineering And Projects Ltd reported the conversion of warrants into 15.60 lakh equity shares by promoters and directors, valued at ₹10.92 Crore.
- Value
- ₹10.92 Cr
Expo Engineering and Projects Other Announcement
Expo Engineering and Projects filed its quarterly shareholding pattern for the period ending September 30, 2026, as required under SEBI regulations.
Other fund raise announcements
All →Rite Zone Chemcon India Fund Raise of ₹6.58 Cr
Rite Zone Chemcon India announced a preferential issue of 27,69,730 equity shares to 11 investors at Rs.24 each, raising about Rs.6.58 Crore. The approval awaits a shareholder vote on 23 November 2026.
- Value
- ₹6.58 Cr
Sudarshan Pharma Industries Fund Raise of ₹72 Cr
Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.
- Value
- ₹72.00 Cr
Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr
Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.
- Value
- ₹68.20 Cr
Kanel Industries Fund Raise of ₹16.99 Cr
Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.
- Value
- ₹16.99 Cr
- Execution
- Rights issue opens 23 November 2026 and closes 30 November 2026
Sudarshan Pharma Industries Fund Raise
Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.
GAIL (India) Fund Raise
GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.